Epeius Biotechnologies Reveals a New Generation of Tools for Medical Gene Delivery
SAN MARINO, Calif. -- Epeius Biotechnologies Corporation today announced the publication of another landmark paper describing recent technological advances in medical gene delivery. The...
Natalie Schultz, M.D. Joins Sher Institute for Reproductive Medicine in Illinois
PEORIA, Ill. -- The Sher Institutes for Reproductive Medicine (SIRM(R)) have announced that Natalie Schultz, M.D. will assume the role of Medical Director of...
Harvard Doctor's New Service Offers Peace of Mind to Florence and Tuscany Travelers
BOSTON, Mass. -- Navigate Health International, an innovator in international medical assistance services, announces its first service line, Florence Medical Assistance. Florence Medical Assistance...
LifeModeler Gives $400K Grant to Inmotion Musculoskeletal Institute
SAN CLEMENTE, Calif. -- A software grant that could lead to orthopedic surgeons being able to immediately gauge the effectiveness of implanted joints has...
Epeius Biotechnologies Rexin-G® for Metastatic Cancer Highlighted by National Cancer Institute Journal
SAN MARINO, Calif. -- Epeius Biotechnologies Corporation today announced that Rexin-G, its lead product in development for metastatic cancer, has been highlighted in a...
Ohio's First and Largest Outpatient Pain Clinic Continues to Grow Despite Weak Economy
CENTERVILLE, Ohio -- Dr. Richard Donnini, President and Founder of the Pain Evaluation & Management Center of Ohio has recently announced that Dr. Mark...
California Foot Surgeon Receives International Recognition
LAKE FOREST, Calif. -- Orange County foot surgeon Dr. Richard Moy is widely recognized as the developer of "virtually pain-free" bunion surgery. Normally, bunion...
Popular Orthopedics Medical Handbook Now Available in Portuguese
NEW YORK, N.Y. -- Due to high demand in Brazil, a popular medical handbook, "Fracture Classifications in Clinical Practice" (ISBN: 978-184-628-0252), has recently been...
With Capzule, Electronic Medical Records Are No Longer Limited to Physicians with Deep Pockets
LATHRUP VILLAGE, Mich. -- Webahn Inc. announces the launch of an online electronic medical records application - Capzule.com. This new system makes it affordable...
PreViser Appoints Dr. Randy R. Nolf Director of Medical Technology
MOUNT VERNON, Wash. -- PreViser Corporation, a leader in oral health risk assessment and management, announced that Dr. Randy R. Nolf, DDS has been...
Jim 'Catfish' Hunter Foundation and The ALS Association Announce Opening of ALS Clinic at Pitt County Memorial Hospital
GREENVILLE, N.C. -- The ALS Association - Jim "Catfish" Hunter Chapter today announced that Pitt County Memorial Hospital will open an Amyotrophic Lateral Sclerosis...
Affinity Healthcare LLC Launches Travel Medicine Services in Illinois
ARLINGTON HEIGHTS, Ill. -- Affinity Healthcare LLC, a medical group practice with northwest Chicago suburban offices located in Buffalo Grove, Wheeling, and Arlington Heights,...
FDA Grants Epeius Biotechnologies Rexin-G® A Third Orphan Drug Designation
SAN MARINO, Calif. -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S. Food and Drug Administration...
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for The Treatment of Osteosarcoma
SAN MARINO, Calif. -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S. Food and Drug Administration...
Fertility Specialist, Steven A. Brody, M.D., Ph.D. to Anchor New San Diego Medical Institute
SAN DIEGO, Calif. -- Sher Institutes for Reproductive Medicine(R) (SIRM) have announced the opening of an office in La Jolla, California, with Dr. Steven...
Pamela Madsen, Founder of American Fertility Association Joins One of the Nation's Largest Infertility Care Networks
LAS VEGAS, Nev. -- The Sher Institutes for Reproductive Medicine(R) announced today that Pamela Madsen has been named as Director of Client/Practice Relations to...
Intravenous Infusions of Epeius Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity
SAN MARINO, Calif. -- Epeius Biotechnologies announced today the results of an on-going Phase I/II study of Rexin-G for metastatic bone and soft tissue...
Detroit Dads Opt for Cosmetic Enhancement, Not Power Tools, This June
STERLING HEIGHTS, Mich. -- "Age is a question of mind over matter. If you don't mind, it doesn't matter," said Satchel Paige... but, if...
Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes
SAN MARINO, Calif. -- ASCO 2008 -- Epeius Biotechnologies announced today that the results of a Phase I Feasibility Study of sequential targeted gene...
M2SYS Fingerprint Software Integrated with Medical Marijuana Dispensary Solution
ATLANTA, Ga. -- M2SYS Technology, an award-winning fingerprint biometrics research and development firm, announced today that it has finalized an agreement with IMCL (Innovative...
TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity without Toxicity
SAN MARINO, Calif. -- Epeius Biotechnologies announced today the promising results of an on-going United States-based Phase I/II study of Rexin-G for metastatic breast...
Affinity Healthcare Receives Accreditation for CT and Ultrasound
ARLINGTON HEIGHTS, Ill. -- Affinity Healthcare LLC's diagnostic imaging practice located at 1051 W. Rand Road, Arlington Heights, IL was recently awarded accreditation for...
PreViser and Oral Health Innovations Ltd Form UK Partnership
MOUNT VERNON, Wash. -- PreViser Corporation (www.previser.com), a Washington State-based provider of patented oral disease and risk assessment technology to the dental profession, announced...
Illinois Based Affinity Healthcare, LLC Adds New Physicians
ARLINGTON HEIGHTS, Ill. -- Affinity Healthcare, LLC is pleased to announce the recent addition of two new physicians to its Internal Medicine clinical staff....
Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy with No Dose Limiting Toxicity
SAN MARINO, Calif. -- Epeius Biotechnologies Corporation announced today that Interim Analysis of an on-going Phase I/II study of Rexin-G for pancreatic cancer confirmed Rexin-G's anti-tumor activity with no major toxicity in patients with metastatic chemotherapy-resistant pancreatic cancer. The clinical trial design includes 5 escalating doses of intravenous Rexin-G.
